| Primary |
| Product Used For Unknown Indication |
26.7% |
| Depression |
15.1% |
| Pain |
9.5% |
| Drug Use For Unknown Indication |
6.0% |
| Insomnia |
5.4% |
| Migraine |
4.0% |
| Fibromyalgia |
3.9% |
| Migraine Prophylaxis |
3.7% |
| Sleep Disorder |
3.5% |
| Anxiety |
3.3% |
| Neuralgia |
3.3% |
| Hypertension |
3.0% |
| Headache |
2.5% |
| Analgesic Therapy |
1.8% |
| Postpartum Depression |
1.6% |
| Procedural Pain |
1.6% |
| Diabetes Mellitus |
1.4% |
| Mental Disorder |
1.4% |
| Asthma |
1.2% |
| Back Pain |
1.2% |
|
| Overdose |
7.6% |
| Toxicity To Various Agents |
7.6% |
| Headache |
5.9% |
| Tachycardia |
5.9% |
| Ventricular Tachycardia |
5.9% |
| Asthma |
5.1% |
| Drug Hypersensitivity |
5.1% |
| Somnolence |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Suicidal Ideation |
5.1% |
| Unresponsive To Stimuli |
5.1% |
| Electrocardiogram Qt Prolonged |
4.2% |
| Intentional Overdose |
4.2% |
| Suicide Attempt |
4.2% |
| Tremor |
4.2% |
| Urinary Retention |
4.2% |
| Vomiting |
4.2% |
| Weight Increased |
4.2% |
| Cardiac Arrest |
3.4% |
| Circulatory Collapse |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
36.2% |
| Drug Use For Unknown Indication |
28.3% |
| Depression |
7.5% |
| Pain |
7.1% |
| Hypertension |
3.7% |
| Bipolar I Disorder |
2.2% |
| Neuralgia |
2.1% |
| Suicide Attempt |
1.5% |
| Cancer Pain |
1.2% |
| Insomnia |
1.2% |
| Mental Disorder |
1.2% |
| Anxiety |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Hiv Infection |
1.0% |
| Overdose |
0.9% |
| Intentional Overdose |
0.8% |
| Back Pain |
0.8% |
| Nausea |
0.8% |
| Fibromyalgia |
0.7% |
| Analgesic Therapy |
0.7% |
|
| Completed Suicide |
18.5% |
| Respiratory Arrest |
16.5% |
| Drug Toxicity |
8.6% |
| Toxicity To Various Agents |
7.6% |
| Death |
5.8% |
| Cardio-respiratory Arrest |
5.6% |
| Suicide Attempt |
5.2% |
| Vomiting |
3.3% |
| Cardiac Arrest |
2.7% |
| Tachycardia |
2.7% |
| Weight Increased |
2.7% |
| Multiple Drug Overdose |
2.6% |
| Overdose |
2.6% |
| Somnolence |
2.6% |
| Serotonin Syndrome |
2.5% |
| Drug Abuse |
2.3% |
| Poisoning |
2.2% |
| Unresponsive To Stimuli |
2.2% |
| Intentional Drug Misuse |
1.9% |
| Syncope |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.4% |
| Drug Use For Unknown Indication |
19.0% |
| Pain |
8.9% |
| Rheumatoid Arthritis |
6.5% |
| Depression |
6.1% |
| Hypertension |
5.0% |
| Multiple Myeloma |
2.9% |
| Prophylaxis |
2.7% |
| Insomnia |
2.5% |
| Multiple Sclerosis |
2.4% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
1.9% |
| Migraine |
1.9% |
| Sleep Disorder |
1.7% |
| Crohn's Disease |
1.6% |
| Fibromyalgia |
1.6% |
| Back Pain |
1.5% |
| Asthma |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Osteoporosis |
1.3% |
|
| Vomiting |
10.8% |
| Weight Decreased |
10.1% |
| Weight Increased |
8.6% |
| Death |
5.8% |
| Tremor |
5.7% |
| Pain |
5.6% |
| Pneumonia |
5.6% |
| Urinary Tract Infection |
5.1% |
| Pyrexia |
4.4% |
| Nausea |
4.3% |
| Somnolence |
3.9% |
| Syncope |
3.9% |
| Type 2 Diabetes Mellitus |
3.6% |
| Dyspnoea |
3.3% |
| Headache |
3.3% |
| Pain In Extremity |
3.3% |
| Drug Ineffective |
3.2% |
| Renal Failure Acute |
3.2% |
| Pulmonary Embolism |
3.1% |
| Vision Blurred |
3.1% |
|
| Interacting |
| Depression |
14.5% |
| Product Used For Unknown Indication |
12.9% |
| Back Pain |
9.7% |
| Hypertension |
7.5% |
| Drug Use For Unknown Indication |
5.6% |
| Hypercholesterolaemia |
5.2% |
| Hiv Infection |
4.8% |
| Insomnia |
4.6% |
| Neuropathy Peripheral |
4.0% |
| Arthritis |
3.6% |
| Hypothyroidism |
3.6% |
| Pain |
3.6% |
| Mental Disorder |
3.2% |
| Schizophrenia |
3.2% |
| Parkinson's Disease |
3.0% |
| Sciatica |
2.4% |
| Fibromyalgia |
2.2% |
| Analgesic Therapy |
2.0% |
| Contraception |
2.0% |
| Fatigue |
2.0% |
|
| Drug Interaction |
19.4% |
| Weight Decreased |
12.2% |
| Vomiting |
9.2% |
| Rash Erythematous |
7.1% |
| Serotonin Syndrome |
7.1% |
| Respiratory Failure |
6.1% |
| Tremor |
5.1% |
| Tachycardia |
4.1% |
| Toxicity To Various Agents |
4.1% |
| Lactic Acidosis |
3.1% |
| Loss Of Consciousness |
3.1% |
| Nausea |
3.1% |
| Antipsychotic Drug Level Above Therapeutic |
2.0% |
| Fatigue |
2.0% |
| Inappropriate Antidiuretic Hormone Secretion |
2.0% |
| Inflammation |
2.0% |
| Labile Blood Pressure |
2.0% |
| Muscle Disorder |
2.0% |
| Muscle Rigidity |
2.0% |
| Nervous System Disorder |
2.0% |
|
